Alentis Therapeutics Appoints Lung Experts Professors Tony Mok and Steven Nathan to its Scientific Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BASEL, Switzerland (BUSINESS WIRE) #CLDN1 Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong a.
The global wearable medical devices market is growing faster due to various market drivers, but technological advancements and developments are the main drivers
/PRNewswire/ InsightAce Analytic Pvt. Ltd. announced the publication of a market research report titled " Global Clinical-Grade Wearable Market (By Product.